Ground breaking clues as to how the pioneering heart drug ticagrelor might reduce the risk of dying following a heart attack, in comparison to previous standard treatments have been discovered by scientists from the University of Sheffield. The new findings, published in iPlatelets/i, show that ticagrelor may reduce the risk of dying as a result of a lung infection after suffering a heart attack compared to patients treated with the drug clopidogrel. The ...You have just read an article categorized health
titled Lung Infections Offer Clue to Help Unravel the Mystery of Life-saving Heart Drug.
Written by:
editor - Wednesday, October 16, 2013
There are currently no comments for "Lung Infections Offer Clue to Help Unravel the Mystery of Life-saving Heart Drug"
Post a Comment